Plasma nitrate+nitrite levels are regulated by ovarian steroids but do not correlate with trabecular bone mineral density in rats

Journal of Endocrinology

Volumn 159, Issue 1, 1998, Pages 27-34

  Van Bezooijen, R L ^a   Que, I ^a   Ederveen, A G H ^b   Kloosterboer, H J ^b   Papapoulos, S E ^a   Lowik C W G M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NV ORGANON   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

16ALPHA ETHYL 21 HYDROXY 19 NORPREGN 4 ENE 3,20 DIONE; ESTRADIOL; ETHINYLESTRADIOL; MIFEPRISTONE; N BUTYL 11 (3,17BETA DIHYDROXYESTRA 1,3,5(10) TRIEN 7ALPHA YL) N METHYLUNDECANAMIDE; NITRATE; NITRITE; TIBOLONE;

ANIMAL MODEL; ARTICLE; BONE ATROPHY; BONE DENSITY; BONE METABOLISM; BONE MINERAL; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HORMONAL REGULATION; NONHUMAN; ORAL DRUG ADMINISTRATION; OVARIECTOMY; OVARY FUNCTION; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; TRABECULAR BONE;

ANABOLIC AGENTS; ANIMALS; BONE DENSITY; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; ESTROGEN ANTAGONISTS; ETHINYL ESTRADIOL; FEMALE; GONADAL STEROID HORMONES; NITRATES; NITRITES; NORPREGNENES; OVARIECTOMY; POLYUNSATURATED ALKAMIDES; PREGNENEDIONES; PROGESTERONE CONGENERS; RATS; RATS, WISTAR;

EID: 0031721099     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1590027     Document Type: Article

References (51)

1. Abdalla HI, McKay Hart D, Lindsay R, Leggate I & Hooke A 1985 Prevention of bone mineral loss in postmenopausal women by norethisterone. Obsterics and Gynecology 66 789-792.
2. Baulieu EE 1989 Contragestion and other clinical applications of RU 486, an antiprogesterone at the receptor. Science 245 1351-1357.
3. Barbagallo M, Carbognani A, Palummeri E, Chiavarini M, Pedrazzoni M, Bracchi PG & Passeri M 1989 The comparative effects of ovarian hormone administration on bone mineral status in oophorectomized rats. Bone 10 113-116.
4. Barengolts EI, Gajardo HF, Rosol TJ, D'anza JJ, Pena M, Botsis J & Kukreja SC 1990 Effects of progesterone on postovariectomy bone loss in aged rat. Journal of Born and Mineral Research 5 1143-1147.
5. Bjarnason NH, Bjarnason K, Haarbo J, Rosenquist C & Christiansen C 1996 Tibolone: prevention of bone loss in late postmenopausal women, Journal of Clinical Endocrinology and Metabolism 81 2419-2422.
6. Cicinelli E, Ignarro LJ, Lograno M, Galantino P, Balzano G & Schonauer LM 1996 Circulating levels ot nitric oxide in fertile women in relation to the menstrual cycle. Fertility and Sterility 66 1036-1038.
7. Conrad KP, Joffe GM, Kruszyna H, Kruszyna R, Kochelle LG, Smith RP, Chavez JE & Mosher MD 1993 Identification of increased nitric oxide biosynthesis during pregnancy in rats. FASEB Journal 7 566-571.
8. Damoulis PD & Hauschka PV 1994 Cytokines induce nitric oxide production in mouse osteoblasts. Biochemical and Biophysical Research Communications 201 924-931.
9. Fogelman I, Bessent RR, Smith ML, Hart DM & Lindsay R 1981 Assessment of synthetic steroid (Org OD14): effect on skeletal metabolism by 24 h whole-body retention of disphosphonate. Maturitas 3 265-269.
10. Fox SW, Chambers TJ & Chow JWM 1996 Nitric oxide is an early mediator of the increase in bone formation by mechanical stimulation. American Journal of Physiology 270 E955-E960.
11. 15N]nitrate in biological fluids. Analytical Biochemistry 126 131-138.
12. Hayashi T, Fukuto JM, Ignarro LJ & Chaudhuri G 1992 Basal release of nitric oxide from aortic rings is greater in female rabbits than in male rabbits: implications for atherosclerosis. Proceedings of the National Academy of Sciences of the USA 89 11259-11263.
13. Hayashi T, Yamada K, Esaki T, Kuzuya M, Satake S, Ishikawa, Hidaka H & Iguchi A 1995 Oestrogen increases endothelial nitric oxide by a receptor-mediated system. Biochemical and Biophysical Research Communications 214 847-855.
14. Hibbs JB, Westenfelder C, Taintor R, Vavrin Z, Kablitz C, Baranowski RL, Ward JH, Menlove RL, McMurray MP, Kushner JP & Samlowski WE 1992 Evidence for cytokine-inducible nitric oxide synthesis trom L-arginine in patients receiving interleukin-2 therapy. Journal of Clinical Investigation 89 867-877.
15. Hukkanen M, Hughes FJ, Buttery LDK, Gross SS, Evans TJ, Seddon S, Riveros-Moreno V, MacIntyre I & Polak JM 1995 Cytokine-stimulated expression of inducible nitric oxide synthase by mouse, rat, and human osteoblast-like cells and its functional role in osteoblast metabolic activity. Endocrinology 136 5445-5453.
16. Imthurn B, Rosselli M, Jaeger AW, Keller PJ & Dubey RK 1997 Differential effects of hormone-replacement therapy on endogenous nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17β-oestradiol valerate and cyproterone acetate or medroxyprogesterone acetate. Journal of Clinical Endocrinology and Metabolism 82 388-394.
17. Isserow JA, Rucinski B, Romero DF, Mann GN, Liu CC & Epstein S 1995 The effect of medroxyprogesterone acetate on bone metabolism in the oophorectomized, tamoxifen-treated rat. Endocrinology 136 713-719.
18. G-nitro-L-arginine, and aminoguandine on constitutive and inducible nitric oxide synthase in rat aorta. Biochemical and Biophysical Research Communications 199 147-154.
19. Kasten TP, Collin-Osdoby P, Patel N, Osdoby P, Krukowski M, Misko TP, Settle SL, Currie MG & Nickols GA 1994 Potentiation of osteoclast bone-resorption activity by inhibition of nitric oxide synthase. Proceedings of the National Academy of Sciences of the USA 91 3569-3573.
20. Kawano H, Motoyama K, Kugiyama K, Hirashima O, Ohgushi M, Yoshimura M, Ogawa H, Okumura K & Yasue H 1996 Menstrual cyclic variation of endothelium-dependent vasodilation of the brachial artery: possible role of oestrogen and nitric oxide. Proceedings of the Association of American Physicians 108 473-480.
21. Kharitonov SA, Logan-Sinclair RB, Busset CM & Shinebourne EA 1994 Peak expiratory nitric oxide differences in men and women: relation to the menstrual cycle. British Heart Journal 72 243-245.
22. Kuhl H 1990 Pharmacokinetics of oestrogens and progestogens. Maturitas 12 171-197.
23. Lindsay R, Hart DM & Kraszewski A 1980 Prospective double-blind trial of synthetic steroid (Org OD14) for preventing postmenopausal osteoporosis. British Medical Journal 280 1207-1209.
24. Löwik CWGM, Nibbering PH, van de Ruit M & Papapoulos SE 1994 Inducible production of nitric oxide in osteoblast-like cells and in fetal mouse bone explants is associated with suppression of osteoclastic bone resorption. Journal of Clinical Investigation 93 1465-1472.
25. Lyritis GP, Karpathios S, Basdekis K, Grigoriou O, Katostaras T, Paspati T, Stamatopoulos T, Siampalioti G & Lyritis PG 1995 Prevention of post-oophorectomy bone loss with tibolone. Maturitas 22 247-253.
26. MacIntyre I, Zaidi M, Alam ASMT, Datta HK, Moonga BS, Lidbury PS, Hecker M & Vane JR 1991 Osteoclastic inhibition: an action of nitric oxide not mediated by cyclic GMP. Proceedings of the National Academy of Sciences of the USA 88 2936-2940.
27. Misko TP, Moore WM, Kasten TP, Nickols GA, Corbett JA, Tilton RG, McDaniel ML, Williamson JR & Currie MG 1993 Selective inhibition ot the inducible nitric oxide by aminoguanidine. European Journal of Pharmacology 233 119-125.
28. Prior JC 1990 Progesteron as a bone-tropic hormone. Endocrine Reviews 11 386-398.
29. Ralston SH & Grabowski PS 1996 Mechanisms of cytokine induced bone resorption: role of nitric oxide, cyclic guanosine monophosphate, and prostaglandins. Bone 19 29-33.
30. Ralston SH, Todd D, Helfrich M, Benjamin N & Grabowski PS 1994 Human osteoblast-like cells produce nitric oxide and express inducible nitric oxide synthase. Endocrinology 135 330-336.
31. Ralston SH, Ho LP, Helfrich MH, Grabowski PS, Johnston PW & Benjamin N 1995 Nitric oxide: a cytokine-induced regulator of bone-resorption. Journal of Bone and Mineral Research 10 1040-1049.
32. Ramsay B, Johnson MR, Leone AM & Steer PJ 1995 The effect of exogenous oestrogen on nitric oxide production in women: a placebo controlled crossover study. British Journal of Obstetrics and Gynaecology 102 417-419.
33. Riancho JA, Salas E, Zarrabeitia MT, Olmos JM, Amado JA, Fernández-Luna JL & González-Macías J 1995 Expression and functional role of nitric oxide synthase in osteoblast-like cells. Journal of Bone and Mineral Research 10 439-446.
34. Rosselli M, Imthurm B, Macas E, Keller PJ & Dubey RK 1994 Circulating nitrite/nitrate levels increase with follicular development: indirect evidence for oestradiol mediated NO release. Biochemical and Biophysical Research Communications 202 1543-1552.
35. Rosselli M, Imthurn B, Keller PJ, Jackson EK & Dubey RK 1995 Circulating nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17β-oestradiol and norethisterone acetate: a two-year follow-up study. Hypertension 25 848-853.
36. Rymer J, Chapman MG & Fogelman I 1994 Effect ot tibolone on postmenopausal bone loss. Osteoporosis International 4 314-319.
37. Shultz PJ & Raij L 1992 Endogenously synthesized nitric oxide prevents endotoxin-induced glomerular thrombosis. Journal of Clinical Investigation 90 1718-1725.
38. Stern PH & Diamond J 1992 Sodium nitroprusside increases cyclic GMP in fetal rat bone cells and inhibits resorption of fetal rat limb bones. Research Communications in Chemical Pathology and Pharmacology 75 19-28.
39. Tax L, Goorissen EM & Kicovic PM 1987 Clinical profile of Org OD14. Maturitas 9 3-13.
40. Tsukahara H, Miura M, Tsuchida S, Hata I, Hata K, Yamamoto K, Ishii Y, Muramatsu I & Sudo M 1996 Effect of nitric oxide inhibitors on bone metabolism in growing rats. American Journal of Physiology 270 E840-E845.
41. Turner HC, Takano Y, Owan I & Murrell GAC 1996 Nitric oxide inhibitor L-NAME suppresses mechanically induced bone formation in rats. American Journal of Physiology 270 E634-E639.
42. Turner HC, Owan I, Jacob DS, McClintock R & Peacock M 1997 Effects of nitric oxide synthase inhibitors on bone formation in rats. Bone 21 487-490.
43. Vies van der J 1987 Pharmacological studies with (7 alpha, 17 alpha)-17-hydroxy-7-methyl-19-norpregn-5(10)-en-2-yn-3-on (Org OD14). Maturitas (Suppl 1) 15-24.
44. Visser de J, Coert A, Feenstra H & Vies van der J 1984 Endocrinological studies with (7α,17α)-17-hydroxy-7-methyl-19-norpregn-5(10)-en-20-yn-3-one (Org OD14). Arzneimittel Forschung/Drug Research 34 1010-1017.
45. 15N-labeled nitrate in humans: effect of diet supplementation with ascorbic acid. Cancer Research 43 1921-1925.
46. Wakeling AE & Bowler J 1987 Steriodal pure antioestrogens. Journal of Endocrinology 112 R7-R10.
47. Wasserman AE 1978 The nitrate-nitrosamine situation: a review. Food Engineering 50 110-116.
48. Weiner CP, Lizasoain I, Baylis SA, Knowles RG, Charles IG & Moncada S 1994 Induction of calcium-dependent nitric oxide synthases by sex hormones. Proceedings of the National Academy of Sciences of the USA 91 5212-5216.
49. Whitehead M & Lobo RA 1988 Progestagen use in postmenopausal women. Lancet 26 1243-1244.
50. Wimalawansa SJ, De Marco G, Gangula P & Yallampalli C 1996 Nitric oxide donor alleviates ovariectomy-induced bone loss. Bone 18 301-304.
51. Yallampalli C, Byam-Smith M, Nelson SO & Garfield RE 1994 Steroid hormones modulate the production of nitric oxide and cGMP in the rat uterus. Endocrinology 134 1971-1974.